$0.71 EPS Expected for CAI International (CAI); Shorts at Amedisys (AMED) Raised By 1.05%

October 13, 2017 - By Ellis Scott

Analysts expect CAI International Inc (NYSE:CAI) to report $0.71 EPS on November, 7.They anticipate $0.55 EPS change or 343.75% from last quarter’s $0.16 EPS. CAI’s profit would be $13.67 million giving it 10.62 P/E if the $0.71 EPS is correct. After having $0.65 EPS previously, CAI International Inc’s analysts see 9.23% EPS growth. The stock decreased 1.85% or $0.57 on October 13, reaching $30.17. About 104,444 shares traded. CAI International Inc (NYSE:CAI) has risen 166.86% since October 13, 2016 and is uptrending. It has outperformed by 150.16% the S&P500.

Amedisys Incorporated (NASDAQ:AMED) had an increase of 1.05% in short interest. AMED’s SI was 2.66M shares in October as released by FINRA. Its up 1.05% from 2.64M shares previously. With 246,000 avg volume, 11 days are for Amedisys Incorporated (NASDAQ:AMED)’s short sellers to cover AMED’s short positions. The SI to Amedisys Incorporated’s float is 8.09%. The stock decreased 0.42% or $0.2 during the last trading session, reaching $47.8. About 214,712 shares traded. Amedisys Inc (NASDAQ:AMED) has risen 15.02% since October 13, 2016 and is uptrending. It has underperformed by 1.68% the S&P500.

Among 14 analysts covering Amedisys Inc. (NASDAQ:AMED), 5 have Buy rating, 0 Sell and 9 Hold. Therefore 36% are positive. Amedisys Inc. had 27 analyst reports since September 1, 2015 according to SRatingsIntel. The company was upgraded on Monday, January 11 by Raymond James. RBC Capital Markets maintained Amedisys Inc (NASDAQ:AMED) rating on Friday, May 6. RBC Capital Markets has “Sector Perform” rating and $48 target. On Tuesday, April 5 the stock rating was downgraded by Obsidian Research Group to “Market Perform”. The rating was initiated by Wells Fargo with “Outperform” on Tuesday, September 1. Jefferies maintained the stock with “Buy” rating in Tuesday, September 5 report. As per Friday, January 27, the company rating was initiated by Benchmark. RBC Capital Markets maintained Amedisys Inc (NASDAQ:AMED) on Monday, June 5 with “Hold” rating. The stock has “Neutral” rating by Mizuho on Wednesday, July 26. Mizuho downgraded the shares of AMED in report on Wednesday, November 11 to “Neutral” rating. The stock of Amedisys Inc (NASDAQ:AMED) earned “Buy” rating by Mizuho on Monday, November 7.

Amedisys, Inc. is a healthcare services company. The company has market cap of $1.62 billion. The Company’s divisions are Home Health, Hospice, Personal Care and Other. It has a 40.67 P/E ratio. The Firm is a well-known provider of home health, hospice and personal care services.

Investors sentiment increased to 1.75 in 2017 Q2. Its up 0.69, from 1.06 in 2017Q1. It is positive, as 9 investors sold Amedisys Inc shares while 42 reduced holdings. 32 funds opened positions while 57 raised stakes. 30.18 million shares or 2.20% less from 30.86 million shares in 2017Q1 were reported. Deutsche National Bank & Trust Ag has 0% invested in Amedisys Inc (NASDAQ:AMED). Capstone Asset Mgmt holds 5,659 shares or 0.01% of its portfolio. Minnesota-based Foundry Prtn Ltd Com has invested 0.14% in Amedisys Inc (NASDAQ:AMED). Price T Rowe Associates Inc Md accumulated 12,380 shares. Sg Americas Securities Limited Liability Company reported 3,743 shares. Swiss Natl Bank accumulated 0% or 47,500 shares. New York-based Etrade Limited Co has invested 0.02% in Amedisys Inc (NASDAQ:AMED). New York-based Alliancebernstein Ltd Partnership has invested 0% in Amedisys Inc (NASDAQ:AMED). Moreover, Aperio Grp Incorporated Limited Co has 0.01% invested in Amedisys Inc (NASDAQ:AMED). The Wisconsin-based Timpani Mngmt Ltd has invested 1.83% in Amedisys Inc (NASDAQ:AMED). Moreover, Peak6 Invs Lp has 0% invested in Amedisys Inc (NASDAQ:AMED) for 2,558 shares. Credit Suisse Ag accumulated 70,910 shares or 0% of the stock. Millrace Asset Grp Inc Inc accumulated 25,900 shares. Nuveen Asset Mngmt Limited Co holds 19,661 shares. Tower Rech Lc (Trc) stated it has 0% of its portfolio in Amedisys Inc (NASDAQ:AMED).

Since May 8, 2017, it had 1 buying transaction, and 4 selling transactions for $4.35 million activity. $1.40 million worth of stock was sold by Ginn Scott G on Monday, May 8. Hall Linda J. sold $300,800 worth of Amedisys Inc (NASDAQ:AMED) on Friday, May 12. On Friday, May 12 NETTERVILLE JAKE L sold $600,000 worth of Amedisys Inc (NASDAQ:AMED) or 10,000 shares. PERKINS BRUCE D had bought 500 shares worth $29,845. $2.09 million worth of Amedisys Inc (NASDAQ:AMED) was sold by Pernosky Lawrence R.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com